首页> 外文期刊>Journal of Diagnostic Pathology ~ College of Pathologists of Sri Lanka >Testing for human epidermal growth factor receptor 2 in breast cancer; the revised ASO/CAP recommendations 2013

【24h】

Testing for human epidermal growth factor receptor 2 in breast cancer; the revised ASO/CAP recommendations 2013

机译：在乳腺癌中检测人表皮生长因子受体2; 2013年ASO / CAP修订建议

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

No abstract availableJournal of Diagnostic Pathology 2014; 9(2): 1-13

机译：无摘要可用诊断病理学杂志2014; 9（2）：1-13

著录项

来源
《Journal of Diagnostic Pathology ~ College of Pathologists of Sri Lanka》 |2015年第2期|共13页
作者
M Bilous;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类病理学;
关键词

相似文献

外文文献
中文文献
专利

1. Testing for human epidermal growth factor receptor 2 in breast cancer; the revised ASO/CAP recommendations 2013 [J] . M Bilous Journal of Diagnostic Pathology ~ College of Pathologists of Sri Lanka . 2015,第2期

机译：在乳腺癌中检测人表皮生长因子受体2; 2013年ASO / CAP修订建议
2. Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers [J] . Singh Kamaljeet, Tantravahi Umadevi, Lomme Michele M., Breast cancer research and treatment. . 2016,第3期

机译：更新的2013年美国病理学家学院/美国临床肿瘤学会（CAP / ASCO）对人表皮生长因子受体2（HER2）荧光原位杂交（FISH）检测的指南建议增加了HER2阳性和HER2模棱两可的乳腺癌病例; 836例浸润性乳腺癌HER2 FISH结果的回顾性研究
3. Comparative analysis of human epidermal growth factor receptor 2 (HER2) testing in breast cancer according to 2007 and 2013 American Society of Clinical Oncology / College of American Pathologist guideline recommendations (ASCO/CAP) [J] . Wernicke A., De la Iglesia P., Garcia Rivello H. Virchows Archiv: an international journal of pathology . 2018,第Suppla1期

机译：2007年和2013年美国临床肿瘤学会乳腺癌人体表皮生长因子受体2（HER2）检测的对比分析/美国病理学家指南建议（ASCO / CAP）
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
6. The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology [O] . Christian Garbar, Aude-Marie Savoye, Corinne Mascaux, 2014

机译：由美国临床肿瘤学会/美国病理学家学院的最新更新建议所建议的乳腺癌人表皮生长因子受体2筛查试验将涉及欧洲病理学实验室的原位杂交试验
7. Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer [O] . Tse Hui Lim, Alvin Soon Tiong Lim, Aye Aye Thike, 2016

机译：美国临床肿瘤学会/美国病理学家学院的含义对人体表皮生长因子受体2基因试验使用免疫组化和荧光原位杂交对乳腺癌的指导建议

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号